Year |
Citation |
Score |
2019 |
Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. The New England Journal of Medicine. PMID 31050279 DOI: 10.1056/Nejmoa1900866 |
0.3 |
|
2016 |
Kessler RA, Mealy MA, Levy M. Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic. Current Treatment Options in Neurology. 18: 2. PMID 26705758 DOI: 10.1007/S11940-015-0387-9 |
0.315 |
|
2015 |
Probasco JC, Hawley G, Burnett M, Gibson L, Carter K, Harlow E, Russell H, Huffman L, Adams J, Ziegler T, Sporney H, Levy M, Puttgen HA. Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement Project. The Neurohospitalist. 5: 197-204. PMID 26425247 DOI: 10.1177/1941874415576206 |
0.309 |
|
2015 |
Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, et al. Update on biomarkers in neuromyelitis optica. Neurology® Neuroimmunology & Neuroinflammation. 2: e134. PMID 26236760 DOI: 10.1212/Nxi.0000000000000134 |
0.32 |
|
2015 |
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85: 177-89. PMID 26092914 DOI: 10.1212/Wnl.0000000000001729 |
0.316 |
|
2014 |
Levy M. Does aquaporin-4-seronegative neuromyelitis optica exist? Jama Neurology. 71: 271-2. PMID 24424919 DOI: 10.1001/Jamaneurol.2013.5865 |
0.306 |
|
2013 |
Saini H, Rifkin R, Gorelik M, Huang H, Ferguson Z, Jones MV, Levy M. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. Bmc Neurology. 13: 104. PMID 23927715 DOI: 10.1186/1471-2377-13-104 |
0.515 |
|
2012 |
Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis Archives of Neurology. 69: 1176-1180. PMID 22733096 DOI: 10.1001/Archneurol.2012.314 |
0.304 |
|
2010 |
Saini H, Fernandez G, Kerr D, Levy M. Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity. Journal of Neuroimmunology. 221: 68-72. PMID 20227773 DOI: 10.1016/J.Jneuroim.2010.02.007 |
0.488 |
|
2003 |
Levy M, Faas GC, Saggau P, Craigen WJ, Sweatt JD. Mitochondrial regulation of synaptic plasticity in the hippocampus. The Journal of Biological Chemistry. 278: 17727-34. PMID 12604600 DOI: 10.1074/Jbc.M212878200 |
0.5 |
|
2002 |
Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, Brown SE, Sweatt JD, Craigen WJ. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. The Journal of Biological Chemistry. 277: 18891-7. PMID 11907043 DOI: 10.1074/Jbc.M201649200 |
0.596 |
|
2002 |
Schrader LA, Anderson AE, Varga AW, Levy M, Sweatt JD. The other half of Hebb: K+ channels and the regulation of neuronal excitability in the hippocampus. Molecular Neurobiology. 25: 51-66. PMID 11890457 DOI: 10.1385/Mn:25:1:051 |
0.607 |
|
Show low-probability matches. |